Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML
NCT00820976
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
260
Enrollment
OTHER
Sponsor class
Conditions
AML
Interventions
DRUG:
G-CSF
Sponsor
Turkish Leukemia Study Group